These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8603406)

  • 1. Dual action of tirapazamine in the induction of DNA strand breaks.
    Jones GD; Weinfeld M
    Cancer Res; 1996 Apr; 56(7):1584-90. PubMed ID: 8603406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
    Shinde SS; Anderson RF; Hay MP; Gamage SA; Denny WA
    J Am Chem Soc; 2004 Jun; 126(25):7865-74. PubMed ID: 15212534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.
    Anderson RF; Shinde SS; Hay MP; Denny WA
    J Am Chem Soc; 2006 Jan; 128(1):245-9. PubMed ID: 16390153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
    Birincioglu M; Jaruga P; Chowdhury G; Rodriguez H; Dizdaroglu M; Gates KS
    J Am Chem Soc; 2003 Sep; 125(38):11607-15. PubMed ID: 13129365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: the drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions.
    Hwang JT; Greenberg MM; Fuchs T; Gates KS
    Biochemistry; 1999 Oct; 38(43):14248-55. PubMed ID: 10571998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced conversion of DNA radical damage to double strand breaks by 1,2,4-benzotriazine 1,4-dioxides linked to a DNA binder compared to tirapazamine.
    Anderson RF; Harris TA; Hay MP; Denny WA
    Chem Res Toxicol; 2003 Nov; 16(11):1477-83. PubMed ID: 14615975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and post-irradiation radiosensitization by SR 4233.
    Zeman EM; Brown JM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):967-71. PubMed ID: 2703404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirapazamine: laboratory data relevant to clinical activity.
    Brown JM; Wang LH
    Anticancer Drug Des; 1998 Sep; 13(6):529-39. PubMed ID: 9755717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
    Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for bimodal DNA damage induced by tirapazamine.
    Daniels JS; Gates KS; Tronche C; Greenberg MM
    Chem Res Toxicol; 1998 Nov; 11(11):1254-7. PubMed ID: 9815184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    Org Biomol Chem; 2005 Jun; 3(11):2167-74. PubMed ID: 15917906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage from oxidants: influence of lesion complexity and chromatin organization.
    Olive PL; Johnston PJ
    Oncol Res; 1997; 9(6-7):287-94. PubMed ID: 9406234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.
    Inbaraj JJ; Motten AG; Chignell CF
    Chem Res Toxicol; 2003 Feb; 16(2):164-70. PubMed ID: 12588187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
    Siim BG; Menke DR; Dorie MJ; Brown JM
    Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2).
    Chowdhury G; Junnotula V; Daniels JS; Greenberg MM; Gates KS
    J Am Chem Soc; 2007 Oct; 129(42):12870-7. PubMed ID: 17900117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks.
    Banáth JP; Olive PL
    Cancer Res; 2003 Aug; 63(15):4347-50. PubMed ID: 12907603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice.
    Olive PL; Vikse CM; Banath JP
    Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.